APA (7th ed.) Citation

CS, S., P, C., M, M., A, G., S, V., B, W., . . . R, B. (2023). Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. Clinical pharmacology and therapeutics, 114(3), 644. https://doi.org/10.1002/cpt.2953

Chicago Style (17th ed.) Citation

CS, Shemesh, et al. "Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework." Clinical Pharmacology and Therapeutics 114, no. 3 (2023): 644. https://doi.org/10.1002/cpt.2953.

MLA (9th ed.) Citation

CS, Shemesh, et al. "Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework." Clinical Pharmacology and Therapeutics, vol. 114, no. 3, 2023, p. 644, https://doi.org/10.1002/cpt.2953.